Lexaria Bioscience Corp

LEXXW:NASDAQ
RT Quote | NASDAQ | USD
Last | 4:00 PM EST
1.50quote price arrow down-0.01 (-0.66%)
Volume
18,113
52 week range
0.60 - 1.70

...

Loading . . .

KEY STATS

  • Open1.60
  • Day High1.69
  • Day Low1.35
  • Prev Close1.51
  • 52 Week High1.70
  • 52 Week High Date01/14/21
  • 52 Week Low0.60
  • 52 Week Low Date01/12/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Lexaria Bioscience Corp News

There is no recent news for this security.

Latest LEXXW News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Lexaria Bioscience Corp is a healthcare company. The Company is primarily engaged in developing drug delivery technology, DehydraTECH, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company's technology can be applied to many different ingestible product formats, including foods, beverages...
Christopher Bunka
Chairman
John Docherty
President
Allan Spissinger
Chief Financial Officer
Address
100 - 740 MCCURDY ROAD
Kelowna, BC
V1X 2P7
Canada